As RNAi-mediated inactivation of these genes partially suppressed toxic TDP-43 phenotypes, their normal cellular functions may promote TDP-43 toxicity, making them potential targets for treating TDP-43 proteinopathy. Here, TARDBP is linked to proteostasis deficiencies.